D2Dopamine Receptors Reduce N-Type Ca2+Currents in Rat Neostriatal Cholinergic Interneurons Through a Membrane-Delimited, Protein-Kinase-C-Insensitive Pathway
- 1 February 1997
- journal article
- research article
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 77 (2) , 1003-1015
- https://doi.org/10.1152/jn.1997.77.2.1003
Abstract
Yan, Zhen, Wen-Jie Song, and D. James Surmeier. D2dopamine receptors reduce N-type Ca2+currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 77: 1003–1015, 1997. Dopamine has long been known to regulate the activity of striatal cholinergic interneurons and the release of acetylcholine. Yet, the cellular mechanisms by which this regulation occurs have not been elucidated. One way in which dopamine might act is by modulating voltage-dependent Ca2+channels. To test this hypothesis, the impact of dopaminergic agonists on Ca2+channels in neostriatal cholinergic interneurons was studied by combined whole cell voltage-clamp recording and single-cell reverse transcription–polymerase chain reactions. Cholinergic interneurons were identified by the presence of choline acetyltransferase mRNA. Nearly all interneurons tested (90%, n = 17) coexpressed D2(short and long isoforms) and D1b(D5) dopamine receptor mRNAs. D1areceptor mRNA was found in only a small subset (20%) of the sample and D3and D4receptor mRNAs were undetectable. D2receptor agonists rapidly and reversibly reduced N-type Ca2+currents. D1b/D1areceptor activation had little or no effect on Ca2+currents. The D2receptor antagonist sulpiride blocked the effect of D2agonists. Dialysis with guanosine-5′-O-(2-thiodiphosphate) or brief exposure to the G protein (Gi/o) alkylating agent N-ethylmaleimide also blocked the D2modulation. The reduction in N-type currents was neither accompanied by kinetic slowing nor significantly reversed by depolarizing prepulses. The D2receptor effects were mediated by a membrane-delimited pathway, because the modulation was not seen in cell-attached patches when agonist was applied to the bath and was not disrupted by perturbations in cytosolic signaling pathways known to be linked to D2receptors. Activation of M2 muscarinic receptors occluded the D2modulation, suggesting a shared signaling element. However, activation of protein kinase C attenuated the M2 modulation without significantly affecting the D2modulation. Taken together, our results suggest that activation of D2dopamine receptors in cholinergic interneurons reduces N-type Ca2+currents via a membrane-delimited, Gi/oclass G protein pathway that is not regulated by protein kinase C. This signaling pathway may underlie the ability of D2receptors to reduce striatal acetylcholine release.Keywords
This publication has 72 references indexed in Scilit:
- Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunitsNeuron, 1995
- VIP inhibits N-type Ca2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathwayNeuron, 1994
- Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neuronsNeuron, 1993
- Enhancement of N- and L-type calcium channel currents by protein kinase C in frog sympathetic neuronsNeuron, 1993
- Structure and Functional Expression of an ω-Conotoxin-Sensitive Human N-Type Calcium ChannelScience, 1992
- Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cellsNeuron, 1992
- Pheromone-induced phosphorylation of a G protein β subunit in S. cerevisiae is associated with an adaptive response to mating pheromoneCell, 1991
- Specific inhibitors of protein kinase C block transmitter-induced modulation of sensory neuron calcium currentNeuron, 1989
- Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependenceNature, 1989
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984